Categories
Business

White Home says states cannot buy Covid vaccine instantly

Ron Klain, former White House Ebola Response Coordinator, speaks during a hearing for the House Subcommittee on Homeland Security in Washington, DC, the United States, on Tuesday, March 10, 2020.

Andrew Harrer | Bloomberg | Getty Images

White House Chief of Staff Ron Klain said Sunday that US states are unable to purchase Covid-19 vaccines directly from manufacturers, as some are trying to do under emergency use approval issued by the Food and Drug Administration to have.

“This vaccine is subject to emergency approval for legal reasons,” Klain told NBC’s Meet the Press when asked about the inquiries. “I don’t think that’s possible.”

The comments come after New York Governor Andrew Cuomo on Monday asked Pfizer CEO Albert Bourla to allow the state to buy vaccines directly from the company, citing the scarcity of supplies.

Pfizer told Cuomo that it would not be able to do so under the terms of his December emergency clearance.

The company said it was open to the idea, but “before we could sell directly to state governments, HHS would need to approve this proposal based on the EUA granted to Pfizer by the FDA.”

The Department of Health and Human Services – still under Republican leadership at the time – accused Democrat Cuomo of trying “to get to the top of the line at the expense of other jurisdictions”.

Klain said he believed governors were “understandably frustrated” with the slow pace of vaccinations to date.

The number of vaccines administered falls far short of projections made under President Donald Trump, although the pace has picked up in recent weeks. President Joe Biden has pledged the US will administer 100 million doses of vaccine in his first 100 days in office.

“We’re going to ramp up production. We’re going to ramp up sales. We’re going to work closely with the governors. We’re going to get this vaccine out to the American people,” Klain said.

The Biden government has urged the federal government to strengthen its role in the manufacture and distribution of Covid-19 vaccines.

TJ Ducklo, a White House spokesman, previously opposed state efforts to buy vaccines direct, saying, “We need to take a national approach to vaccination and make sure states don’t compete against each other as they do with PPE, ventilators and others. ” Testing. “

Ducklo didn’t immediately respond to an email on Sunday. The Department of Health and Human Services also did not immediately respond to a request for comment.

Before Biden took office, other states had asked Trump’s Department of Health and Human Services to allow them to buy vaccines directly from the manufacturer.

The governors of Michigan, Minnesota and Wisconsin – all Democrats – sent a letter on Jan. 15 accusing the Trump administration of botching the introduction of the first vaccine.

“If you cannot or do not want to give us this shipment, we urge you to give us permission to buy vaccines directly so we can distribute them,” wrote the governors.

At least one of those states appears to have been tracking the plan since Biden was inaugurated on Wednesday.

Bobby Leddy, a spokesperson for Michigan Governor Gretchen Whitmer, said in a statement to CBS: “We are confident that President Joe Biden will have a clear national strategy, based on data and science, to help our nation overcome this To help health crisis. ” “”

Subscribe to CNBC Pro for the live TV stream, deep insights and analysis of how to invest during the next president’s term.

Categories
Health

Neglect ‘Dry January’ and Different New 12 months’s Resolutions

“The world is on fire,” said Asia Wong, clinical social worker and director of counseling and health services at Loyola University in New Orleans. “Why are you trying to lose 20 pounds?”

Last year Rebecca Fletcher, a teacher in Wirral, England, said she went without alcohol for the whole month of January.

After indulging in Prosecco over the holidays, she decided to repeat that success.

Ms. Fletcher, 49, said she gave up after two weeks.

“I’m sorry, dry January. It just doesn’t work, ”she said on Twitter, posting a photo of a glass of Pinot Grigio. “It’s not you. Since I am.”

Ms. Fletcher said her attempt to sober up for a month was thwarted by the surge in Covid-19 cases, which led the government to order a full lockdown and created confusion in schools, where teachers and students are constant were unsure when to return to the classroom. And political instability in the United States didn’t help, she said.

“It just feels like anywhere, it’s stressful,” Ms. Fletcher said. “Not to mention it’s England, of course, and it rained hard for three days.”

You shouldn’t be too hard on yourself, say the experts.

Sarah Wakeman, an addiction medicine specialist at Massachusetts General Hospital in Boston, said the all-or-nothing approach to substance discontinuation could make people feel ashamed or disappointed.

“This is an unprecedented time,” she said. “We all have to allow ourselves a little grace.”

And while a promise to stay sober for a month can be a great way for a person to assess why they are drinking and what they like or dislike about drinking, there are downsides to cutting off alcohol completely for a set period of time .

This approach “might make some people drink heavier once they start drinking again,” said Dr. Wakeman. “For example, someone may feel reassured that they have been able to stop drinking and have less to watch out for the rest of the year.”

Nathian Shae Rodriguez, a professor of journalism and media studies at San Diego State University, made two promises to himself in December: say “no” more often and answer emails faster.

“I’m a first-generation Mexican-American professor, a queer-of-color professor, and that in and of itself involves a lot of invisible work that people don’t recognize,” he said.

Students seek him for advice and faculty members often ask him to speak at lectures on gay and immigrant rights or ask him to join committees, Professor Rodriguez said.

The vows he made for 2021 felt like a simple and necessary time gift to himself.

“I was on the swing for the first few days,” said Professor Rodriguez, 39. He politely declined various requests to sit on committees and write letters of recommendation from students he did not know well.

Then came January 6th and the siege of the Capitol. The students were scared and confused and searched for him on social media wherever he was active. Professor Rodriguez said gay students from conservative families particularly felt unrelated.

“They needed confirmation that everything would be fine,” he said. Saying no felt impossible.

An effective way to come up with a solution is to remember that you have 11 months left to meet your goals, said Ms. Wong, the social worker.

“This is a good time to take stock,” she said. “This is a good time to think and say, ‘If I could change things, what would I change?'”

Then she added, “Commit to this as a year-round plan.”

Humans are hardwired to deal with stress through escape and reward, said Judy Grisel, a professor of psychology at Bucknell University and a behavioral neuroscientist.

Ideally, this escape should be through movement, such as running or walking.

But often, especially in January in the northern hemisphere, when the days are still short and warmer regions are cold and bleak, fleeing means having a drink, sitting in front of the TV or taking a smartphone and mindlessly scrolling through social media.

People believe that if they just have to exercise, they can break out of bad habits, she said.

Movement, she said, “is an untapped resource.”

Dr. Grisel described a friend who quit smoking by running around the block every time he craved a cigarette. It’s harder to take this advice when it’s freezing outside, she admitted.

“I think that’s part of the January problem,” said Dr. Grisel. “It’s so dark and cold that we don’t want to move. This is a very difficult time, probably the most difficult time to change. “

So the movement we choose can be very small: play a guitar or call a friend, she said.

“My favorite thing to do is pick up trash,” said Dr. Grisel. “I just grabbed a plastic bag and went to the side of the road to pick up trash. It helps that I move and can see the change on the street. “

And we have good news. The days for this half of the world are getting longer, the sun sets later, and a geologist has found a rock formation that looks like Cookie Monster. Things are looking up.

Categories
Entertainment

Walter Bernstein, Celebrated Screenwriter, Is Useless at 101

“Suddenly the blacklist for the writer had reached what he had only been aiming for before,” joked Mr Bernstein in “Inside Out”. “It was deemed necessary.”

It was the now largely forgotten “This kind of woman” (1959) with Sophia Loren that restarted Mr. Bernstein’s “official” career. The director of the film was Mr. Lumet, who hired Mr. Bernstein under his own name and thus effectively put him back into the ranks of the employees.

In the blacklisted years, Mr. Bernstein worked regularly for Hollywood, although he continued to live in New York. His films include the westerns “The Wonderful Country” (1959) and “Heller in Pink Tights” (1960), the Harold Robbins adaptation “The Betsy” (1978) and the Dan Aykroyd-Walter Matthau comedy “The Couch Trip” “. (1988). He received an Emmy nomination for the television drama “Miss Evers’ Boys” (1997), based on the true story of a 1932 government experiment in which black test subjects were allowed to die of syphilis, and wrote the television game for the live broadcast of “Fail Safe “in 2000.

In addition to his wife, a literary agent, a daughter, Joan Bernstein, and a son, Peter Spelman, survive in Bernstein from his first marriage to Marva Spelman, who was divorced. three sons, Nicholas, Andrew and Jake, from his third marriage to Judith Braun, who also divorced, as well as a brief second marriage; his stepdaughter Diana Loomis; five grandchildren; two great-grandchildren; and a sister, Marilyn Silk.

Six decades later, Mr. Bernstein gave a warmly nostalgic look at the Red Scare era, an era that has become synonymous with intolerance and fear.

“I don’t know if it’s true that other people get older,” he said, “but in some ways I look back on that time with a certain fondness for relationships, support, and friendships. We helped each other during this time. And in a dog food dog store that was pretty rare. “

Categories
Business

If Poor Nations Go Unvaccinated, a Examine Says, Wealthy Ones Will Pay

Durch die Monopolisierung der Impfstoffversorgung gegen Covid-19 drohen den reichen Nationen mehr als eine humanitäre Katastrophe: Die daraus resultierenden wirtschaftlichen Verwüstungen werden die wohlhabenden Länder fast genauso hart treffen wie die in den Entwicklungsländern.

Dies ist die entscheidende Erkenntnis aus einer akademischen Studie, die am Montag veröffentlicht werden soll. Im extremsten Szenario – mit reichen Nationen, die bis Mitte dieses Jahres vollständig geimpft waren, und armen Ländern, die weitgehend geschlossen sind – kommt die Studie zu dem Schluss, dass die Weltwirtschaft Verluste von mehr als 9 Billionen US-Dollar erleiden würde, eine Summe, die über der Jahresproduktion Japans und Deutschlands liegt kombiniert.

Fast die Hälfte dieser Kosten würde von wohlhabenden Ländern wie den Vereinigten Staaten, Kanada und Großbritannien übernommen.

In dem Szenario, das Forscher als am wahrscheinlichsten bezeichnen und in dem Entwicklungsländer bis Ende des Jahres die Hälfte ihrer Bevölkerung impfen, würde die Weltwirtschaft immer noch einen Schlag zwischen 1,8 und 3,8 Billionen US-Dollar absorbieren. Mehr als die Hälfte der Schmerzen würde sich auf wohlhabende Länder konzentrieren.

Die von der Internationalen Handelskammer in Auftrag gegebene Studie kommt zu dem Schluss, dass eine gerechte Verteilung der Impfstoffe im wirtschaftlichen Interesse jedes Landes liegt, insbesondere derjenigen, die am stärksten vom Handel abhängen. Es ist eine Zurechtweisung für die weit verbreitete Auffassung, dass der Austausch von Impfstoffen mit armen Ländern lediglich eine Form der Wohltätigkeit ist.

“Natürlich sind alle Volkswirtschaften miteinander verbunden”, sagte Selva Demiralp, Wirtschaftswissenschaftlerin an der Koc-Universität in Istanbul, die zuvor bei der Federal Reserve in Washington gearbeitet hatte, und eine der Autoren der Studie. “Keine Volkswirtschaft wird vollständig wiederhergestellt, wenn die anderen Volkswirtschaften nicht wiederhergestellt werden.”

Frau Demiralp merkte an, dass eine globale philanthropische Initiative namens ACT Accelerator, die darauf abzielt, Entwicklungsländern Pandemieressourcen zur Verfügung zu stellen, Verpflichtungen in Höhe von weniger als 11 Milliarden US-Dollar für ein Ziel von 38 Milliarden US-Dollar eingegangen ist. Die Studie legt die wirtschaftlichen Gründe für das Schließen der Lücke dar. Die verbleibenden 27 Milliarden US-Dollar mögen auf den ersten Blick wie eine enorme Summe aussehen, sind aber im Vergleich zu den Kosten für die Fortsetzung der Pandemie eine Kleinigkeit.

Die alltägliche Idee, dass die Pandemie weder Grenzen noch Rassen- und Klassenunterschiede respektiert, wurde von Unternehmensleitern und Experten gefördert. Dieses tröstliche Konzept wurde durch die Tatsache widerlegt, dass Covid-19 den Tod und die Zerstörung von Lebensgrundlagen bei Niedriglohn-Servicemitarbeitern und insbesondere bei rassistischen Minderheiten trainiert hat, während Angestellte weitgehend sicher von zu Hause aus arbeiten konnten, und einige andere der reichsten Menschen der Welt können die Pandemie auf Yachten und Privatinseln ausreiten.

Aber im Bereich des internationalen Handels gibt es kein Versteck vor dem Coronavirus, wie die Studie zeigt. Stattdessen gibt es globale Lieferketten, die die Teile für die Industrie produzieren und die weiterhin gestört werden, solange das Virus eine Kraft bleibt.

Ein Team von Wirtschaftswissenschaftlern der Koc University, der Harvard University und der University of Maryland untersuchte Handelsdaten in 35 Branchen in 65 Ländern und untersuchte ausführlich die wirtschaftlichen Auswirkungen einer ungleichen Impfstoffverteilung.

Covid19 Impfungen >

Antworten auf Ihre Impfstofffragen

Wenn ich in den USA lebe, wann kann ich den Impfstoff bekommen?

Während die genaue Reihenfolge der Impfstoffempfänger von Staat zu Staat unterschiedlich sein kann, werden die meisten Ärzte und Bewohner von Langzeitpflegeeinrichtungen an erster Stelle stehen. Wenn Sie verstehen möchten, wie diese Entscheidung getroffen wird, hilft dieser Artikel.

Wann kann ich nach der Impfung wieder zum normalen Leben zurückkehren?

Das Leben wird erst wieder normal, wenn die Gesellschaft als Ganzes ausreichend Schutz gegen das Coronavirus erhält. Sobald die Länder einen Impfstoff zugelassen haben, können sie in den ersten Monaten höchstens einige Prozent ihrer Bürger impfen. Die nicht geimpfte Mehrheit bleibt weiterhin anfällig für Infektionen. Eine wachsende Anzahl von Coronavirus-Impfstoffen zeigt einen robusten Schutz vor Krankheit. Es ist aber auch möglich, dass Menschen das Virus verbreiten, ohne zu wissen, dass sie infiziert sind, weil sie nur leichte oder gar keine Symptome haben. Wissenschaftler wissen noch nicht, ob die Impfstoffe auch die Übertragung des Coronavirus blockieren. Selbst geimpfte Menschen müssen vorerst Masken tragen, Menschenmassen in Innenräumen meiden und so weiter. Sobald genügend Menschen geimpft sind, wird es für das Coronavirus sehr schwierig, gefährdete Personen zu finden, die infiziert werden können. Je nachdem, wie schnell wir als Gesellschaft dieses Ziel erreichen, könnte sich das Leben im Herbst 2021 einem normalen Zustand nähern.

Muss ich nach der Impfung noch eine Maske tragen?

Ja, aber nicht für immer. Die beiden Impfstoffe, die möglicherweise in diesem Monat zugelassen werden, schützen die Menschen eindeutig vor einer Krankheit mit Covid-19. Die klinischen Studien, die diese Ergebnisse lieferten, waren jedoch nicht darauf ausgelegt, festzustellen, ob geimpfte Personen das Coronavirus noch verbreiten können, ohne Symptome zu entwickeln. Das bleibt eine Möglichkeit. Wir wissen, dass Menschen, die von Natur aus mit dem Coronavirus infiziert sind, es verbreiten können, ohne Husten oder andere Symptome zu haben. Die Forscher werden diese Frage bei der Einführung der Impfstoffe intensiv untersuchen. In der Zwischenzeit müssen sich selbst geimpfte Menschen als mögliche Spreizer vorstellen.

Wird es wehtun? Was sind die Nebenwirkungen?

Der Impfstoff gegen Pfizer und BioNTech wird wie andere typische Impfstoffe als Schuss in den Arm abgegeben. Die Injektion unterscheidet sich nicht von denen, die Sie zuvor erhalten haben. Zehntausende Menschen haben die Impfstoffe bereits erhalten, und keiner von ihnen hat ernsthafte gesundheitliche Probleme gemeldet. Einige von ihnen haben jedoch kurzlebige Beschwerden verspürt, darunter Schmerzen und grippeähnliche Symptome, die normalerweise einen Tag anhalten. Es ist möglich, dass die Leute planen müssen, nach dem zweiten Schuss einen Tag frei zu nehmen oder zur Schule zu gehen. Obwohl diese Erfahrungen nicht angenehm sind, sind sie ein gutes Zeichen: Sie sind das Ergebnis der Begegnung Ihres eigenen Immunsystems mit dem Impfstoff und einer starken Reaktion, die eine dauerhafte Immunität gewährleistet.

Werden mRNA-Impfstoffe meine Gene verändern?

Nein. Die Impfstoffe von Moderna und Pfizer verwenden ein genetisches Molekül, um das Immunsystem zu stärken. Dieses als mRNA bekannte Molekül wird schließlich vom Körper zerstört. Die mRNA ist in einer öligen Blase verpackt, die mit einer Zelle verschmelzen kann, so dass das Molekül hineinrutschen kann. Die Zelle verwendet die mRNA, um Proteine ​​aus dem Coronavirus herzustellen, die das Immunsystem stimulieren können. Zu jedem Zeitpunkt kann jede unserer Zellen Hunderttausende von mRNA-Molekülen enthalten, die sie produzieren, um eigene Proteine ​​herzustellen. Sobald diese Proteine ​​hergestellt sind, zerkleinern unsere Zellen die mRNA mit speziellen Enzymen. Die mRNA-Moleküle, die unsere Zellen herstellen, können nur wenige Minuten überleben. Die mRNA in Impfstoffen ist so konstruiert, dass sie den Enzymen der Zelle etwas länger standhält, sodass die Zellen zusätzliche Virusproteine ​​bilden und eine stärkere Immunantwort auslösen können. Die mRNA kann jedoch höchstens einige Tage halten, bevor sie zerstört wird.

Wenn Menschen in Entwicklungsländern aufgrund von Sperren, die erforderlich sind, um die Ausbreitung des Virus einzudämmen, arbeitslos bleiben, müssen sie weniger Geld ausgeben, was den Umsatz für Exporteure in Nordamerika, Europa und Ostasien verringert. Multinationale Unternehmen in fortgeschrittenen Ländern werden auch Schwierigkeiten haben, die erforderlichen Teile, Komponenten und Waren zu sichern.

Im Zentrum der Geschichte steht die Tatsache, dass der größte Teil des internationalen Handels keine fertigen Waren umfasst, sondern Teile, die von einem Land in ein anderes geliefert werden, um zu Produkten gefaltet zu werden. Von den Waren im Wert von 18 Billionen US-Dollar, die im vergangenen Jahr gehandelt wurden, machten sogenannte Zwischenprodukte nach Angaben der Organisation für wirtschaftliche Zusammenarbeit und Entwicklung 11 Billionen US-Dollar aus.

Die Studie stellt fest, dass die anhaltende Pandemie in armen Ländern wahrscheinlich am schlimmsten für Branchen ist, die besonders von Zulieferern auf der ganzen Welt abhängig sind, darunter Automobilindustrie, Textilindustrie, Bauwesen und Einzelhandel, in denen der Umsatz um mehr als 5 Prozent sinken könnte.

Die Ergebnisse ergänzen die Grundannahme, dass die Pandemie die Weltwirtschaft ungleicher als je zuvor machen wird, um eine komplizierende Schicht. Während dies wahr erscheint, könnte eine auffällige Form der Ungleichheit – der Zugang zu Impfstoffen – universelle Probleme aufwerfen.

In einem außergewöhnlichen Beweis für die Innovationsfähigkeit der weltweit qualifiziertesten Wissenschaftler haben einige der führenden Pharmaunternehmen in einem kleinen Bruchteil der Zeit, die für möglich gehalten wurde, lebensrettende Impfstoffe hergestellt. Aber die reichsten Länder in Nordamerika und Europa haben Bestellungen für den größten Teil des Angebots abgeschlossen – genug, um das Zwei- und Dreifache ihrer Bevölkerung zu impfen – und die armen Länder haben sich bemüht, ihren Anteil zu sichern.

Viele Entwicklungsländer, von Bangladesch über Tansania bis Peru, werden wahrscheinlich bis 2024 warten müssen, bevor sie ihre Bevölkerung vollständig impfen können.

Die Initiative, arme Länder mit zusätzlichen Ressourcen zu versorgen, gewann mit dem Amtsantritt von Präsident Biden an Bedeutung. Die Trump-Administration hat nicht zur Sache beigetragen. Dr. Anthony S. Fauci, Chief Medical Officer von Herrn Biden für die Pandemie, kündigte umgehend an, dass die Vereinigten Staaten sich der Kampagne zum Austausch von Impfstoffen anschließen würden.

Im Gegensatz zu den Billionen Dollar, die Regierungen in reichen Ländern für die Rettung von Unternehmen und Arbeitnehmern ausgegeben haben, die durch den Gesundheitsnotstand und den wirtschaftlichen Abschwung geschädigt wurden, haben die Entwicklungsländer Schwierigkeiten, darauf zu reagieren.

Da Wanderarbeitnehmer aus armen Ländern während der Pandemie Arbeitsplätze verloren haben, konnten sie nicht so viel Geld nach Hause schicken, was Ländern, die sich auf diese sogenannten Überweisungen verlassen haben, wie den Philippinen, Pakistan und Bangladesch, einen schweren Schlag versetzt.

Die globale Rezession hat die Nachfrage nach Rohstoffen gedrosselt und Kupferproduzenten wie Sambia und die Demokratische Republik Kongo sowie von Öl abhängige Länder wie Angola und Nigeria dezimiert. Da die Fälle von Covid-19 stark angestiegen sind, hat dies den Tourismus gedrückt und Arbeitsplätze und Einnahmen in Thailand, Indonesien und Marokko gekostet.

Viele arme Länder sind mit Schuldenlasten in die Pandemie eingetreten, die einen Großteil ihrer Staatseinnahmen absorbierten und ihre Ausgaben für die Gesundheitsversorgung einschränkten. Private Gläubiger haben sich geweigert, an einem bescheidenen Programm zur Aussetzung der Schulden teilzunehmen, das von der Gruppe der 20 geschmiedet wurde. Die Weltbank und der Internationale Währungsfonds versprachen beide große Erleichterungen, brachten jedoch keine nennenswerten Dollars hervor.

Auch dies scheint sich zu ändern, da eine neue Führung Washington übernimmt. Die Trump-Regierung lehnte eine geplante Ausweitung der sogenannten Sonderziehungsrechte beim IWF um 500 Milliarden US-Dollar ab, einem Reservevermögen, das die Regierungen gegen harte Währungen eintauschen können. Der Aufstieg von Herrn Biden hat die Hoffnungen der Fondsmitglieder gestärkt, dass seine Verwaltung die Expansion unterstützen wird. Demokraten im Kongress – jetzt unter Kontrolle beider Kammern – haben Unterstützung für eine Maßnahme signalisiert, die das Finanzministerium zum Handeln zwingen würde.

In Hauptstädten wie Washington und Brüssel wurde die Diskussion über die Unterstützung der Entwicklungsländer jedoch moralisch gestaltet. Führer haben darüber diskutiert, wie viel sie übrig haben können, um den am wenigsten glücklichen Gemeinschaften des Planeten zu helfen, während sie sich hauptsächlich um ihre eigenen Leute kümmern.

Die Studie fordert diesen Rahmen heraus. Wenn es nicht darum geht, dass die Menschen in den Entwicklungsländern Zugang zu Impfstoffen erhalten, schaden die Staats- und Regierungschefs der reichsten Nationen ihrem eigenen Vermögen.

“Keine Wirtschaft, wie groß sie auch sein mag, wird gegen die Auswirkungen des Virus immun sein, bis die Pandemie überall ein Ende hat”, sagte John Denton, Generalsekretär der Internationalen Handelskammer. „Der Kauf von Impfstoffen für die Entwicklungsländer ist kein Akt der Großzügigkeit der reichsten Nationen der Welt. Es ist eine wesentliche Investition für die Regierungen, wenn sie ihre Binnenwirtschaft wiederbeleben wollen. “

Categories
Politics

Trump thought-about ousting Legal professional Common in push to overturn election

President Donald J. Trump stops to speak to reporters as he boards Marine One and departs from the South Lawn at the White House.

The Washington Post | The Washington Post | Getty Images

Former President Donald Trump had planned earlier this month to oust Jeffrey Rosen as acting attorney general and replace him with a Justice Department attorney who would support his efforts to reverse the presidential election results, the New York Times reported on Friday.

The plan would have replaced Rosen with Jeffrey Clark, the attorney who ran the Department of Justice’s civil division. Clark would then have backed Trump’s unsubstantiated allegations of election fraud and put pressure on Georgia state officials to change the election result.

A Justice Department official familiar with the matter confirmed the Times’ report of Trump’s efforts to NBC News.

Trump’s plan ultimately failed to materialize after Justice Department officials agreed during a conference call that they would resign if Rosen was fired, the Times said.

Trump had asked Rosen to appoint special advisors to investigate his allegations of widespread electoral fraud as well as the Dominion voting machine company, but Rosen declined.

Trump attempted to pressure Georgia’s top polling officer to “find the scam” in December when investigating suspected election fraud in Cobb County. Allegations that state officials believed to be unfounded. Trump also called on Georgian Foreign Minister Brad Raffensperger to “find” votes to postpone the election in his favor.

In a statement to the Times, Clark categorically denied that he had devised a plan to oust Rosen or give recommendations for action based on factual inaccuracies found on the Internet.

The House has accused Trump of instigating an anti-government riot on Jan. 6 after deadly unrest in the Capitol. His impeachment proceedings against the Senate are due to begin in the week of February 8th.

Read the full Times report here

Categories
World News

Barred From U.S. Underneath Trump, Muslims Exult in Biden’s Open Door

Of 45,000 Iranians who applied for a visa waiver between January 2017 and July 2020, only 7,000 received visas, according to the Foreign Ministry. “The impact has been across the board – financial, emotional, educational, professional, romantic,” said Reza Mazaheri, a New York-based immigration attorney who represents many Iranians.

For others, the ban is a closed, tragic chapter.

Mohamed Abdelrahman, a Libyan businessman, believed he hit the jackpot in 2017 when he won a green card lottery that offered an escape route from a country in deep chaos, said his nephew Mohamed Al-Sheikh.

But the Trump ban forced Mr Abdelrahman to delay and before he could leave Libya he suffered a stroke and died.

If there had been no ban, “his life might have been completely different,” said the 34-year-old al-Sheikh over the phone from Tripoli. “He just needed a stable place to live for the rest of his life.”

The reporting was done by Farnaz Fassihi from New York; Vivian Yee from Cairo; Ben Hubbard and Hwaida Saad from Beirut, Lebanon; Abdi Latif Dahir from Nairobi, Kenya; Ruth MacLean from Dakar, Senegal; Mohammed Abdusamee from Tripoli, Libya; Hannah Beech from Bangkok; and Saw Nang from Yangon, Myanmar.

Categories
Business

The Week in Enterprise: Biden Will get Right down to Enterprise

All eyes are now on President Biden. Here’s how his new guidelines will affect businesses and households struggling to survive the pandemic economy – as well as other major business and tech news of the week. Stay safe, everyone. – Charlotte Cowles

President Joseph R. Biden Jr. began his first days in office by signing a series of executive orders to bolster the ailing economy and help those worst hit. He directed his government to expedite the delivery of stimulus checks to millions of eligible Americans who have not yet received them, increase the weekly value of grocery stamps by up to 20 percent, and raise the minimum wage for federal employees to $ 15 each Increase hour. A day earlier, he had decided not to extend the existing federal eviction ban until the end of March at the earliest (it should expire earlier this month), along with the moratorium on foreclosures on state-guaranteed mortgages. It also extends the federal student loan payments freeze through September.

The social networking app Parler, which had become a hub for right-wing conspiracy theorists, will be gone shortly. A federal judge ruled against Parler’s lawsuit forcing Amazon to restore the app’s platform last week, stating it was not in the public interest. Amazon previously supplied Parler’s cloud computing services (as it does for many companies) but revoked them after Parler coordinated the pro-Trump riots at the Capitol on Jan. 6. Parler accused Amazon of partnering with Twitter to take them offline. but could not provide sufficient evidence. The judge also stated that the court will not force Amazon to host it until Parler has put in place a better system for moderating “abusive, violent content”.

Regardless of your thoughts on Bridgerton, we can all agree that Netflix was a pandemic. And the company’s results finally reflect its success. Netflix has relied on borrowed money for years to cover the huge operating costs involved in producing huge amounts of content to feed our couch-bound brains. But not anymore: the company announced last week that it no longer needs to borrow money to support itself. It’s a big change for Netflix, and a thumbs in mind for its skeptics who predicted the company will never break even.

Another item on Mr Biden’s agenda: creating new coronavirus protective measures in the workplace. The president has ordered the labor protection agency to develop new, stricter guidelines for employers to protect their workers from the interception or spread of the virus while at work. Mr. Biden’s order will establish national standards and give OSHA the power to enforce them. This is a big change from the stance of the Trump administration, which has chosen to leave virus precautions to employers. In addition, Mr Biden plans to allow workers to receive unemployment benefits if they quit jobs that do not comply with pandemic protocols. He explains that workers have a state guaranteed right to refuse employment that threatens their health.

Surprise surprise. China failed to keep its promise to buy hundreds of billions of dollars in American products under an initial trade deal with the Trump administration a year ago, before the pandemic decimated both countries’ economies. Now it is up to Mr Biden to decide what to do about it. He will say the previous government’s punitive tariffs on Chinese goods, which also raise prices for American businesses and consumers? Or will he find another way to force Beijing to end its business troubles? It is an early test of the new administration, which has announced it will take a tough stance on China but has also urged it to win the support of United States allies rather than take unilateral action.

It’s still a mess. Mr Biden has invoked the Defense Production Act to expedite coronavirus vaccine production, but the only way manufacturers can move forward is that fast. The process of getting vaccines into people’s arms is also disorganized. Some big employers like Amazon have offered to help with the rollout by monitoring their workers’ vaccinations rather than leaving everything on the congested shoulders of the healthcare system. Large corporate initiatives could help large swathes of the population get vaccinated faster, but they would also give these companies a competitive advantage in getting their employees on the line to be vaccinated.

Several industries had hoped to get back to normal in 2021, but planning large (and costly) events is still difficult. Art Basel, the world’s largest fair for contemporary art, which takes place annually in Switzerland, has been postponed from June to September due to the pandemic. The Glastonbury Music Festival in England, also planned for June, has been canceled for the second time in a row. Still holding on despite reports to the contrary: the Olympic Games in Tokyo. The organizers insist that they host the games from July.

Categories
Health

Voters extra optimistic about Covid, blame feds for vaccine rollout: NBC ballot

USC School of Pharmacy Assistant Professor Richard Dang (R) gives Ashley Van Dyke a Covid-19 vaccine as a mass vaccination of health care workers is happening on January 15, 2021 at Dodger Stadium in Los Angeles, California.

Irfan Khan | AFP | Getty Images

With President Joe Biden making tackling the Covid-19 crisis his top priority, American voters are a little more optimistic about the pandemic than they were last fall, according to a new poll by NBC News.

Still, many respondents are dissatisfied with the sluggish introduction of the vaccine in the country, and a majority blame the federal government, according to the survey.

Poll results released Thursday showed that 38% of registered voters believe the worst of the health crisis is behind the country, while 44% believe the worst is yet to come. In a poll conducted just before the November elections, those numbers were 25% and 55%, respectively.

In his inaugural address on Wednesday, Biden warned of a difficult battle against the impending coronavirus.

“We are entering what is possibly the toughest and deadliest phase of the virus,” he said.

The country has at least 193,600 new coronavirus cases and at least 3,030 Covid deaths every day, based on a 7-day average calculated by CNBC using data from Johns Hopkins University. New, more infectious strains of the virus have emerged in the United States. At least 406,000 Americans have died from the virus since the pandemic started early last year.

The U.S. has failed to meet its target of vaccinating 20 million people by the end of 2020. Under the administration of former President Donald Trump, just over 14.2 million people had received one or more doses of the Covid-19 vaccine on Wednesday morning, according to the CDC.

While respondents to the NBC survey expressed a slight increase in optimism about the pandemic, more than half of respondents were previously dissatisfied with the introduction of vaccines: 30% said vaccine administration went poorly, while 25% said it was bad that they “didn’t” run too well. “

Another 11% said it was handled “very” well, and 31% said it went “fairly” well.

Among those who said the rollout was below average, 64% primarily blamed the federal government, while 21% blamed the state governments. Another 11% blamed both of them the same.

The answers diverged across the party lines. 79% of Democratic voters who criticized the introduction of the vaccine blamed the federal government. Among Republicans who were dissatisfied with the distribution, 52% blamed states.

The poll polled 1,000 registered voters nationwide from January 10-13. The error rate is plus or minus 3.1 percentage points.

Biden’s plan

Biden plans to accelerate vaccine rollout by increasing funding for local and state officials, creating more vaccination sites, and launching a national awareness campaign, according to his Covid Response Plan released Thursday. Previously, Biden said his government will try to give 100 million vaccine shots in the first 100 days.

His incoming health officials have expressed dismay at the state of the federal vaccine distribution plan.

“What we inherit from the Trump administration is so much worse than we could have imagined,” Jeff Zients, Biden’s Covid Response coordinator, told reporters. “We have to vaccinate as much of the US population as possible to get out of this pandemic, but we don’t have the infrastructure.”

On his first day in office, Biden restored the national security team in charge of global health, safety and biological defense, urged authorities to extend statewide moratoriums on evictions and foreclosures, and urged the Department of Education to put a break on student loan payments and interest to extend.

The president has also issued a mask mandate for anyone visiting a federal building or state, or using certain public transportation. Biden launched a 100-Day Masking Challenge that asked Americans to wear face coverings in public for the next 100 days.

Adopting a new Covid aid package will be a challenge for the new Congress and the White House. Democrats have a small majority in both houses of Congress, and Republicans are skeptical about spending increases.

“We have to put politics aside and finally face this pandemic as a nation,” Biden said on Wednesday.

Categories
Business

Ford, IBM, Intel and Seagate

The IBM logo is displayed on a smartphone.

Rafael Henrique | SOPA Pictures | LightRocket | Getty Images

Check out the companies that are making headlines in midday trading.

Ford – The US automaker’s shares fell about 1%, pulling back from an all-time high in the previous session. The stock rose 6.2% on Thursday after Deutsche Bank and Barclays issued positive comments on Ford’s product plans and reported fourth quarter results on February 4. JPMorgan overweighted Ford from equilibrium to Ford on Friday. The stock gained more than 16% this week, making it its best week since June.

IBM – IBM stocks fell 10% after earnings report, which saw revenue decline more than analysts’ expectations. According to Refinitiv, IBM had fourth-quarter revenue of $ 20.37 billion, missing estimates of $ 20.67 billion. However, the result exceeded estimates.

Intel – The chipmaker’s shares fell more than 8% despite the company’s better-than-expected fourth-quarter results. Intel had adjusted earnings per share of $ 1.52 on revenue of $ 20 billion, beating Wall Street’s expectations of $ 1.10 per share and $ 17.49 billion in revenue, according to Refinitiv . Part of the stock price decline was the reverse of a surge in Thursday’s late session that followed an early release of Intel’s results.

CSX Corp. The railroad company’s shares were down more than 2% despite CSX beating revenue and earnings estimates in the fourth quarter. The company reported adjusted earnings per share of $ 1.04, 3 cents above consensus guidance. FactSet estimates that sales were $ 2.83 billion, above the expected $ 2.77 billion.

Seagate Technology – Seagate shares fell nearly 6% despite decent mid-day earnings results. The downward pressure is also likely due to the already high expectations analysts and investors had of the company prior to the quarterly report. Wedbush analyst Matt Bryson wrote on Friday morning: “Without a clear driver for short-term upside moves or the certainty of longer-term technological advantage, we maintain our neutral view of the name.”

PPG Industries – The paint maker’s stock also fell in mid-day trading, despite earnings and sales beating expectations for the fourth quarter. Sam Hudson, an analyst at Atlantic Equities, noted that the company had failed to provide guidance for fiscal 2021 and wrote that a recent rise in raw material costs could affect second quarter results.

– CNBC’s Pippa Stevens, Yun Li, Maggie Fitzgerald and Jesse Pound contributed to the coverage

Categories
Health

The Coronavirus Kills Mink. They Might Get a Vaccine.

At least two American companies and Russian researchers are working on coronavirus vaccines against mink. The animals became sick and died in large numbers from the virus, which they also returned to humans in mutated form.

Zoetis, a large New Jersey veterinary drug company with annual sales of more than $ 6 billion in 2019, and Medgene Labs, a small company with about 35 employees in South Dakota, are both testing vaccines in mink. They apply for a license for their products from the US Department of Agriculture.

Both companies said their vaccine technologies are generally similar to Novavax’s for a human vaccine that is in late-stage trials. In this system, insect cells produce the coronavirus spike protein, which is then bound to a harmless virus that invades the body’s cells and trains the immune system to be prepared for reality.

Mink is known to have been infected with SARS-CoV-2, the pandemic virus, in half a dozen countries around the world.

All members of the weasel family are susceptible to infection and to developing some symptoms and passing the virus on, at least to others of their species. This is in part due to the proteins on the surfaces of their cells and the structure of their respiratory systems. Scientists don’t know why minks in particular seem to get very sick, but the overcrowded conditions in farms on farms can cause them to be exposed to higher levels of virus.

The most serious outbreak was in Denmark, where mink breeding was suspended until at least 2022 due to mutations in the virus that appeared in infected mink.

At the end of last autumn Denmark ordered the slaughter of up to 17 million animals. Most of the dead minks were not allowed to be skinned for the fur trade. In average years the country sells up to 17 million pelts, but last year’s decision also killed its breeding population and there are fears that the industry will not recover.

In the United States, on the other hand, according to an industry group, Fur Commission USA, around 275 mostly small mink farms produce around three million skins annually. Thousands of U.S. minks have been infected and died, but states have been addressing the quarantine issue on some farms. The Ministry of Agriculture did not get involved and there was no order to kill mink populations like in Denmark.

Still, mink infections pose a public health threat in the United States. At least two minks that have escaped from farms have tested positive. And a wild mink tested positive. Scientists fear that if the virus spreads to wilder mink or other animals, it could establish itself in natural populations and create a reservoir from which it could possibly emerge in a mutated form to re-infect humans at another time.

So far, the mutations observed in Danish mink have not turned out to be a problem. But mutations in the virus in infected people have produced at least two variants that are more infectious. If a second species, the mink, serves as another breeding ground for the virus, the likelihood of mutation and escape into other animals increases. Consequently, a mink vaccine could have value beyond the industry. And while the Department of Agriculture is not currently considering applications for vaccines for cats and dogs, this is one option companies are considering.

Covid19 vaccinations>

Answers to your vaccine questions

If I live in the US, when can I get the vaccine?

While the exact order of vaccine recipients may vary from state to state, most doctors and residents of long-term care facilities will come first. If you want to understand how this decision is made, this article will help.

When can I get back to normal life after the vaccination?

Life will only get back to normal once society as a whole receives adequate protection against the coronavirus. Once countries have approved a vaccine, they can only vaccinate a few percent of their citizens in the first few months. The unvaccinated majority remain susceptible to infection. A growing number of coronavirus vaccines show robust protection against disease. However, it is also possible that people spread the virus without knowing they are infected because they have mild or no symptoms. Scientists don’t yet know whether the vaccines will also block the transmission of the coronavirus. Even vaccinated people have to wear masks for the time being, avoid the crowds indoors and so on. Once enough people are vaccinated, it becomes very difficult for the coronavirus to find people at risk to become infected. Depending on how quickly we as a society achieve this goal, life could approach a normal state in autumn 2021.

Do I still have to wear a mask after the vaccination?

Yeah, but not forever. The two vaccines that may be approved this month clearly protect people from contracting Covid-19. However, the clinical trials that produced these results were not designed to determine whether vaccinated people could still spread the coronavirus without developing symptoms. That remains a possibility. We know that people who are naturally infected with the coronavirus can spread it without experiencing a cough or other symptoms. Researchers will study this question intensively when the vaccines are introduced. In the meantime, self-vaccinated people need to think of themselves as potential spreaders.

Will it hurt What are the side effects?

The vaccine against Pfizer and BioNTech, like other typical vaccines, is delivered as a shot in the arm. The injection is no different from the ones you received before. Tens of thousands of people have already received the vaccines, and none of them have reported serious health problems. However, some of them have experienced short-lived symptoms, including pain and flu-like symptoms that usually last a day. It is possible that people will have to plan to take a day off or go to school after the second shot. While these experiences are not pleasant, they are a good sign: they are the result of your own immune system’s encounter with the vaccine and a strong response that ensures lasting immunity.

Will mRNA vaccines change my genes?

No. Moderna and Pfizer vaccines use a genetic molecule to boost the immune system. This molecule, known as mRNA, is eventually destroyed by the body. The mRNA is packaged in an oily bubble that can fuse with a cell, allowing the molecule to slide inside. The cell uses the mRNA to make proteins from the coronavirus that can stimulate the immune system. At any given point in time, each of our cells can contain hundreds of thousands of mRNA molecules that they produce to make their own proteins. As soon as these proteins are made, our cells use special enzymes to break down the mRNA. The mRNA molecules that our cells make can only survive a few minutes. The mRNA in vaccines is engineered to withstand the cell’s enzymes a little longer, so the cells can make extra viral proteins and trigger a stronger immune response. However, the mRNA can last a few days at most before it is destroyed.

Zoetis produces many vaccines for farm animals as well as dogs and cats. For pets, vaccines are made against infectious respiratory diseases in dogs, feline leukemia viruses, and others. The company began work on an animal vaccine in February at the start of the pandemic.

“When we saw the first case of dog infection in Hong Kong, we immediately followed up our normal procedures for developing a vaccine against emerging infectious diseases,” said Mahesh Kumar, senior vice president, Global Biologics, Zoetis. “We have decided to prepare a vaccine for dogs and cats.”

However, upon news of mink infections, the company reached out to the US Department of Agriculture and obtained permission to test the vaccine in mink. In the past, it took several months from testing to approval of other vaccines.

Dr. Kumar pointed out that coronavirus veterinary vaccines are common, for example for avian infectious bronchitis. The disease was first identified in the 1930s and a number of companies make vaccines.

Medgene, an early-stage small company, began work on coronavirus vaccine technology for animals in response to a devastating disease affecting pigs in China in 2013, the epidemic swine diarrhea virus. Mark Luecke, the company’s chief executive officer, said that as soon as the news of the pandemic became known last year and the coronavirus was identified and its genetic sequence described, a team “immediately started work on a vaccine that is for animals is suitable “.

Not knowing which animals would be susceptible, the company began testing it on mice, as it usually does with vaccine developers. When mink was found to be particularly vulnerable, the company contacted people in the mink industry and began testing the virus. Mr Lücke said it should be feasible to produce it this spring pending licensing.

Outside the US, other researchers are also working on mink vaccines. Researchers in Russia and Finland are tracking animal vaccines that could be used on mink and other animals.